About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

KAN-004 for Immune-Related Diarrhea or Colitis | Clinical Trials | Clareo Health

RECRUITINGPhase 1

KAN-004 for Immune-Related Diarrhea or Colitis

A Phase I Study of KAN-004 in Patients With Immune-Related Diarrhea or Colitis

NCT07196410•Centre hospitalier de l'Université de Montréal (CHUM)

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

ColitisDiarrhea Caused by Antitumor Drugs

Interventions

KAN-004

Locations

1

Canada

Locations (1)

Centre Hospitalier de l'Universite de Montreal

Montreal, Quebec, Canada

Key Dates

Start Date

March 1, 2026

Primary Completion Date

December 31, 2028

Completion Date

December 31, 2030

Last Updated

April 13, 2026

Related Studies

RECRUITINGPhase 4

Upadacitinib Versus Infliximab as Second-Line Treatment for Acute Severe Ulcerative Colitis（UPRISE）

NCT07550673

Acute Severe Ulcerative Colitis

RECRUITINGPhase 1/2

Superdonor FMT in Patients With Ulcerative Colitis

NCT05739864

Active Ulcerative Colitis

Eosinophilic Gastrointestinal Disorders Registry

NCT05199532

Eosinophilic EsophagitisEosinophilic Gastroenteritis+2 more

Effectiveness of Ozanimod in Patients With Steroid-Dependent Ulcerative Colitis

NCT07271069

Ulcerative Colitis (UC)

Observational Study To Assess The Effectiveness and Treatment Adherence Of Tofacitinib of Ulcerative Colitis In Clinical Practice In Sweden

NCT04338204

Ulcerative Colitis

RECRUITINGPhase 2/3

A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis

NCT05076175

Colitis, Ulcerative

View all related studies

Contacts

Wiam Belkaid, PhD

CONTACT

514-836-3273 wiam.belkaid.chum@ssss.gouv.qc.ca

Sponsors

Lead Sponsor

Centre hospitalier de l'Université de Montréal (CHUM)

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 13, 2026Data synced to Clareo: April 27, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions